Call +1 (833) 552-7181 or Contact us Earn $25 in coupons on your first order with Aladdin!
Toggle Nav
My Cart
Search
Advanced Search
Menu
Sign In
྾
main product photo

CD13 Mouse mAb - Primary antibody, specific to CD13, Mouse IgG1

Features and benefits
  • Short Overview:

    mAb (WM15); Mouse anti Human CD13 Antibody; Flow; Unconjugated

  • Species reactivity(Reacts with): Human
  • Isotype: Mouse IgG1
    Application:
  • Flow Cytometry
Item Number
Ab093787
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab093787-10μg
10μg
In stock
$26.90
Ab093787-50μg
50μg
In stock
$69.90
Ab093787-100μg
100μg
In stock
$99.90
Ab093787-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$899.90
Add to Wish List Compare
Bulk Order  DATASHEET

mAb (WM15); Mouse anti Human CD13 Antibody; Flow; Unconjugated

View related series
Click to view target information: ANPEP
Accession#:P15144 ANPEP CD13 Gene ID:290

Basic Description

Product NameCD13 Mouse mAb - Primary antibody, specific to CD13, Mouse IgG1
Synonymsalanyl (membrane) aminopeptidase; Alanyl aminopeptidase; Aminopeptidase M; Aminopeptidase N; ANPEP; AP-M; APN; AP-N; CD13 antigen; CD13; CD13APN; EC 3.4.11; EC 3.4.11.2; gp150; LAP1; Microsomal aminopeptidase; Myeloid plasma membrane glycoprotein CD13; p1
Specifications & PurityExactAb™, Validated, Carrier Free, Lot by Lot
Host speciesMouse
SpecificityCD13
ConjugationUnconjugated
GradeCarrier Free, ExactAb™, Validated
Product Description

Mouse anti Human CD13 Antibody, Monoclonal (WM15), could be used for Flow and so on.

Application

Flow: < 0.5 μg/100w cells

Protein Function

Broad specificity aminopeptidase. Plays a role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases. May play a critical role in the pathogenesis of cholesterol gallstone disease. May be involved in the metabolism of regulatory peptides of diverse cell types including small intestinal and tubular epithelial cells, macrophages, granulocytes and synaptic membranes from the CNS. Found to cleave antigen peptides bound to major histocompatibility complex class II molecules of presenting cells and to degrade neurotransmitters at synaptic junctions. Is also implicated as a regulator of IL-8 bioavailability in the endometrium, and therefore may contribute to the regulation of angiogenesis. Is used as a marker for acute myeloid leukemia and plays a role in tumor invasion. In case of human coronavirus 229E (HCoV-229E) infection, serves as receptor for HCoV-229E spike glycoprotein. Mediates as well human cytomegalovirus (HCMV) infection.

Product Properties

IsotypeMouse IgG1
Light Chain Typekappa
SDS-PAGE150 kDa
Purification MethodProtein A purified
FormLiquid
ConcentrationLot by Lot
Storage TempStore at 2-8°C
Shipped InWet ice
Stability And StorageShipped at 4°C. Store at 4°C long term (36 months). Upon delivery aliquot.

Images

CD13 Mouse mAb (Ab093787) - Flow Cytometry
Flow Cytometry analysis of HUVEC cells labelling CD13 (red) with CD13 Mouse mAb (Ab093787) at 0.1 μg/mL for 1 hour at 4°C. AffiniPure Goat anti-Mouse IgG, Fcγ fragment specific (Alexa Fluor® 647) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, mouse IgG (Ab170221). Black - Unlabelled control, cells without incubation with primary antibody.

CD13 Mouse mAb (Ab093787) - Flow Cytometry
Flow Cytometry analysis of HepG2 cells labelling CD13 (red) with CD13 Mouse mAb (Ab093787) at 0.1 μg/mL for 1 hour at 4°C. AffiniPure Goat anti-Mouse IgG, Fcγ fragment specific (Alexa Fluor® 647) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, mouse IgG (Ab170221). Black - Unlabelled control, cells without incubation with primary antibody.

CD13 Mouse mAb (Ab093787) - Flow Cytometry
Flow Cytometry analysis of SK-N-SH cells labelling CD13 (red) with CD13 Mouse mAb (Ab093787) at 0.1 μg/mL for 1 hour at 4°C. AffiniPure Goat anti-Mouse IgG, Fcγ fragment specific (Alexa Fluor® 647) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, mouse IgG (Ab170221). Black - Unlabelled control, cells without incubation with primary antibody.

CD13 Mouse mAb (Ab093787) - Flow Cytometry
Flow Cytometry analysis of Hela cells labelling CD13 (red) with CD13 Mouse mAb (Ab093787) at 0.1 μg/mL for 1 hour at 4°C. AffiniPure Goat anti-Mouse IgG, Fcγ fragment specific (Alexa Fluor® 647) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, mouse IgG (Ab170221). Black - Unlabelled control, cells without incubation with primary antibody.

CD13 Mouse mAb (Ab093787) - Flow Cytometry
Flow Cytometry analysis of A549 cells labelling CD13 (red) with CD13 Mouse mAb (Ab093787) at 0.1 μg/mL for 1 hour at 4°C. AffiniPure Goat anti-Mouse IgG, Fcγ fragment specific (Alexa Fluor® 647) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, mouse IgG (Ab170221). Black - Unlabelled control, cells without incubation with primary antibody.

Associated Targets(Human)

ANPEP Tchem Aminopeptidase N (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ANPEP Tchem Aminopeptidase N (863 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ANPEP Tchem Aminopeptidase (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Application

ApplicationDilution info
Flow Cytometry

< 0.5µg/100w cells

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0102455Certificate of AnalysisJan 18, 2024 Ab093787
ZJ24F0102454Certificate of AnalysisJan 18, 2024 Ab093787
ZJ24F0102453Certificate of AnalysisJan 18, 2024 Ab093787

Related Documents

 SDS

 Specification Sheet

References

1. Bonnard E, Poras H, Nadal X, Maldonado R, Fournié-Zaluski MC, Roques BP.  (2015)  Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain..  Pharmacol Res Perspect,  3  (2): (e00116).  [PMID:25692029]
2. Chen H, Noble F, Roques BP, Fournié-Zaluski MC.  (2001)  Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugs..  J Med Chem,  44  (21): (3523-30).  [PMID:11585456]
3. Pascual I, Valiente PA, García G, Valdés-Tresanco ME, Arrebola Y, Díaz L, Bounaadja L, Uribe RM, Pacheco MC, Florent I et al..  (2017)  Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)..  Biochimie,  142  (3): (216-225).  [PMID:28964831]
4. Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV.  (1992)  Human aminopeptidase N is a receptor for human coronavirus 229E..  Nature,  357  (6377): (420-2).  [PMID:1350662]
5. Bonavia A, Zelus BD, Wentworth DE, Talbot PJ, Holmes KV.  (2003)  Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E..  J Virol,  77  (4): (2530-8).  [PMID:12551991]
6. Pinto M, Rougeot C, Gracia L, Rosa M, García A, Arsequell G, Valencia G, Centeno NB.  (2012)  Proposed Bioactive Conformations of Opiorphin, an Endogenous Dual APN/NEP Inhibitor..  ACS Med Chem Lett,  3  (1): (20-4).  [PMID:24900367]
7. Alan H M Wong,Dongxia Zhou,James M Rini.  (2012-08-31)  The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing..  The Journal of biological chemistry,  287  ((44)): (36804-36813).  [PMID:22932899]
8. Kawai M, BaMaung NY, Fidanze SD, Erickson SA, Tedrow JS, Sanders WJ, Vasudevan A, Park C, Hutchins C, Comess KM, Kalvin D, Wang J, Zhang Q, Lou P, Tucker-Garcia L, Bouska J, Bell RL, Lesniewski R, Henkin J, Sheppard GS..  (2006)  Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties..  Bioorg Med Chem Lett,  16  (13): (3574-3577).  [PMID:16632353]
9. Ahn JH, Shin MS, Jun MA, Jung SH, Kang SK, Kim KR, Rhee SD, Kang NS, Kim SY, Sohn SK, Kim SG, Jin MS, Lee JO, Cheon HG, Kim SS..  (2007)  Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors..  Bioorg Med Chem Lett,  17  (9): (2622-2628).  [PMID:17331715]
10. Vassiliou S, Węglarz-Tomczak E, Berlicki Ł, Pawełczak M, Nocek B, Mulligan R, Joachimiak A, Mucha A..  (2014)  Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases..  J Med Chem,  57  (19): (8140-8151).  [PMID:25192493]
11. Węglarz-Tomczak E, Berlicki Ł, Pawełczak M, Nocek B, Joachimiak A, Mucha A..  (2016)  A structural insight into the P1S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases..  Eur J Med Chem,  117  (187-196).  [PMID:27100031]
12. Węglarz-Tomczak E, Burda-Grabowska M, Giurg M, Mucha A..  (2016)  Identification of methionine aminopeptidase 2 as a molecular target of the organoselenium drug ebselen and its derivatives/analogues: Synthesis, inhibitory activity and molecular modeling study..  Bioorg Med Chem Lett,  26  (21): (5254-5259).  [PMID:27692546]
13. Sattigeri JA, Sethi S, Davis JA, Ahmed S, Rayasam GV, Jadhav BG, Chilla SM, Datta D, Gadhave A, Tulasi VK, Jain T, Voleti S, Benjamin B, Udupa S, Jain G, Singh Y, Srinivas K, Bansal VS, Ray A, Bhatnagar PK, Cliffe IA..  (2017)  Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome..  Bioorg Med Chem Lett,  27  (11): (2313-2318).  [PMID:28442252]
14. Singh R, Williams J, Vince R..  (2017)  Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies..  Eur J Med Chem,  139  (325-336).  [PMID:28803047]
15. Jiang Y, Li X, Hou J, Huang Y, Wang X, Jia Y, Wang Q, Xu W, Zhang J, Zhang Y..  (2018)  Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy..  Eur J Med Chem,  143  (334-347).  [PMID:29202398]
16. Yang YK, Shen DD, He P, Du LD, Wan DJ, Wang P, Wang T, Feng MQ..  (2019)  Chemically synthesized LYRM03 could inhibit the metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo..  Bioorg Med Chem Lett,  29  (14): (1719-1726).  [PMID:31126854]
17. Jiang Y,Hou J,Li X,Huang Y,Wang X,Wu J,Zhang J,Xu W,Zhang Y.  (2016)  Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity..  Bioorg Med Chem,  24  (22.0): (5787-5795).  [PMID:27670098]
18. Shapiro, L H LH, Ashmun, R A RA, Roberts, W M WM and Look, A T AT..  (1991)  Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells..  The Journal of biological chemistry,    (25):   [PMID:1675638]
19. O'Connell, P J PJ, Gerkis, V V and d'Apice, A J AJ..  (1991)  Variable O-glycosylation of CD13 (aminopeptidase N)..  The Journal of biological chemistry,    (5):   [PMID:1705556]
20. Look, A T AT, Ashmun, R A RA, Shapiro, L H LH and Peiper, S C SC..  (1989)  Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N..  The Journal of clinical investigation,      [PMID:2564851]
21. Olsen, J J and 9 more authors..  (1988)  Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA..  FEBS letters,    (10):   [PMID:2901990]
22. Tokioka-Terao, M M, Hiwada, K K and Kokubu, T T..  (1984)  Purification and characterization of aminopeptidase N from human plasma..  Enzyme,      [PMID:6149934]
23. Watanabe, Y Y, Iwaki-Egawa, S S, Mizukoshi, H H and Fujimoto, Y Y..  (1995)  Identification of an alanine aminopeptidase in human maternal serum as a membrane-bound aminopeptidase N..  Biological chemistry Hoppe-Seyler,      [PMID:7576235]
24. Favaloro, E J EJ, Browning, T T and Facey, D D..  (1993)  CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated..  Experimental hematology,      [PMID:7902291]
25. Núñez, L L and 6 more authors..  (1993)  Cholesterol crystallization-promoting activity of aminopeptidase-N isolated from the vesicular carrier of biliary lipids..  FEBS letters,    (23):   [PMID:8102610]
26. Söderberg, C C and 5 more authors..  (1993)  CD13 (human aminopeptidase N) mediates human cytomegalovirus infection..  Journal of virology,      [PMID:8105105]
27. Kolb, A F AF, Maile, J J, Heister, A A and Siddell, S G SG..  (1996)  Characterization of functional domains in the human coronavirus HCV 229E receptor..  The Journal of general virology,      [PMID:8887485]
28. Norén, K K and 5 more authors..  (1997)  Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity..  Experimental cell research,    (25):   [PMID:9056417]
29. Kolb, A F AF, Hegyi, A A and Siddell, S G SG..  (1997)  Identification of residues critical for the human coronavirus 229E receptor function of human aminopeptidase N..  The Journal of general virology,      [PMID:9367365]
30. Dong, X X and 5 more authors..  (2000)  Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells..  Journal of immunology (Baltimore, Md. : 1950),    (1):   [PMID:10605003]
31. Pasqualini, R R and 9 more authors..  (2000)  Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis..  Cancer research,    (1):   [PMID:10676659]
32. Seli, E E, Senturk, L M LM, Bahtiyar, O M OM, Kayisli, U A UA and Arici, A A..  (2001)  Expression of aminopeptidase N in human endometrium and regulation of its activity by estrogen..  Fertility and sterility,      [PMID:11384645]
33. Wentworth, D E DE and Holmes, K V KV..  (2001)  Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation..  Journal of virology,      [PMID:11559807]
34. van Hensbergen, Yvette Y and 7 more authors..  (2002)  Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid..  Clinical cancer research : an official journal of the American Association for Cancer Research,      [PMID:12473585]
35. Kristiansen, Troels Zakarias TZ and 8 more authors..  (2004)  A proteomic analysis of human bile..  Molecular & cellular proteomics : MCP,      [PMID:15084671]
36. Kramer, Werner W and 11 more authors..  (2005)  Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane..  The Journal of biological chemistry,    (14):   [PMID:15494415]
37. Liu, Tao T and 6 more authors..  ()  Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry..  Journal of proteome research,      [PMID:16335952]
38. Zody, Michael C MC and 68 more authors..  (2006)  Analysis of the DNA sequence and duplication history of human chromosome 15..  Nature,    (30):   [PMID:16572171]
39. Bian, Yangyang Y and 9 more authors..  (2014)  An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome..  Journal of proteomics,    (16):   [PMID:24275569]
40. Thomas R Burkard,Melanie Planyavsky,Ines Kaupe,Florian P Breitwieser,Tilmann Bürckstümmer,Keiryn L Bennett,Giulio Superti-Furga,Jacques Colinge.  (2011-01-29)  Initial characterization of the human central proteome..  BMC systems biology,  5  (17-17).  [PMID:21269460]

Solution Calculators

Privacy Policy Website Terms of Use Return policy Terms and Conditions of Sale Cookie Policy Sales Policy
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Copyright © 2023-present Aladdin Scientific Corp . All rights reserved.